Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users.
Kevin O. St. Arnaud, Donald Sharpe
Journal of Psychoactive Drugs 2023 DOI: 10.1080/02791072.2022.2039815 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 511 |
| Population | Psychedelic drug users |
| Keywords | Psychedelics Drug policy Entheogens Harm reduction Positive drug use Recreational drug use |
| Citations | 31 |
| Key findings | Recreational psychedelic use can enhance or diminish mental health depending on contextual factors: frequent use and coping motives predict negative mental health, while group use, self-expansive intentions, and post-use integration predict positive mental health. |
Abstract
Growing research exploring the utility of psychedelic substances suggests that they not only hold promise for clinical practice but may enhance mental health through recreational use as well. However, given the importance of set and setting for maximizing benefits and minimizing harms of drug use, it is important to develop a foundational understanding of the contextual factors associated with positive and negative mental health in psychedelic users. Accordingly, data were collected using an internet-based survey of psychedelic drug users (n = 511). Hierarchical regression analyses were used to explore to what degree life-time use, frequency of use, dose size, group use, intentions for use, and post-use integration predict mental health in psychedelic users. In particular, using psychedelics with high frequency and to cope with negative affect were found to predict negative mental health. Conversely, using psychedelics in a group setting, with self-expansive intentions, and integrating post-use were found to predict positive mental health. Findings suggest that recreational psychedelic use may either enhance or diminish mental health depending on the contextual parameters of use. Limitations and areas for further research are discussed.
Citations in the library
Cited by 32
- Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020 Journal of Psychopharmacology March 6, 2023
- A framework for assessment of adverse events occurring in psychedelic-assisted therapies Journal of Psychopharmacology July 31, 2024
- From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS). Scientific Reports January 29, 2025
- Psychological effects of psychedelics in adolescents. Front Child Adolesc Psychiatry June 7, 2024
- Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges. CNS Drugs October 1, 2024
and 27 more in the library
Cites 19
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psychedelics and the essential importance of context. Journal of Psychopharmacology February 15, 2018
- Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI) Frontiers in Human Neuroscience June 14, 2016
- Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology Journal of Psychopharmacology November 16, 2016
- Predicting Responses to Psychedelics: A Prospective Study Frontiers in Pharmacology November 2, 2018
and 14 more in the library